Home » Medical Cannabis Research » Medical Cannabis Study

The Accessibility and Understanding Gap in Medical Cannabis in California: My MMJ Doctor's 2026 Primary Study



Originally Published: July 30, 2026



Last Updated: October 5, 2026

Fact Checked

Written byRobert D. Saint LaurentMaster of Education

Reviewed byMy MMJ Doctor TeamEditorial Team



Originally Published: July 30, 2026



Last Updated: October 5, 2026

This study examines the gap between accessibility and patient understanding of medical cannabis in California using data from 526 participants. While access to medical cannabis has improved significantly through legalization and telehealth expansion, findings reveal persistent gaps in eligibility awareness, process clarity, and trust in digital platforms. Key results show that 62% of participants were unsure about eligibility, 48% questioned telehealth legitimacy, and 57% did not know about the benefits of having a medical marijuana card. The study highlights that accessibility alone does not drive patient action- confidence and clarity play a critical role. Addressing these gaps may improve patient awareness and informed decision-making.

Introduction

In 2026, access to medical cannabis in California is more streamlined than ever. With both medical and recreational cannabis legalized and the rapid expansion of telehealth platforms, patients can now connect with licensed providers and obtain medical marijuana recommendations with ease and from the comfort of their homes.

On paper, the system works. But access is only one part of the equation.

As we spent more time examining patient experiences, a different pattern began to emerge. While people knew where to go, many weren’t sure how the process actually worked or whether they even qualified in the first place.

This study was conducted to better understand that gap.

Using data from 526 participants across California, along with behavioral insights from real patient interactions, we focused on one question: Does easier access to medical cannabis also mean better understanding?

Research Objective

The objective of this study was to evaluate the gap between accessibility and understanding of medical cannabis by examining:

Patient awareness of medical cannabis programs
Understanding of eligibility, process, and benefits
The role of stigma in influencing decision-making
The effectiveness of telehealth in improving clarity
Behavioral differences between recreational users and potential medical patients

Methodology

This study used a structured, observational research approach, combining quantitative survey data with qualitative behavioral insights.

A total of 526 participants were included in the study, comprising 327 individuals who interacted with telehealth platforms and 199 consumers from licensed dispensaries across California.

Data Collection Period

Data was collected between January and March 2026.

Participant Criteria

Participants were selected based on:

Prior cannabis use (medical or recreational), or
Active interest in exploring medical cannabis programs

Data Collection Methods

Structured survey questionnaires
Platform-based behavioral observations
Self-reported participant responses

Sampling Technique

The study used a convenience sampling method, supported by behavioral segmentation to differentiate between exploratory users and active cannabis consumers.

Data Validation

Responses were reviewed for completeness and internal consistency. Incomplete or inconsistent entries were excluded from the final dataset to ensure accuracy and reliability.

Accessibility Has Outpaced Patient Understanding

One of the first things that stood out during the research was how common uncertainty still is, even in a state like California.

Despite full legalization and easy access:

62% of participants were unsure whether they qualified for a medical marijuana card
54% reported a limited understanding of the difference between medical and recreational cannabis

This wasn’t about availability. Most participants already knew where to go and how to begin.

The hesitation came from uncertainty. Some assumed they wouldn’t qualify. Others felt the process might be more complicated than it actually is. A few simply didn’t trust that they understood it correctly.

What became clear is that while access has improved significantly, the level of understanding is what needs to be addressed.

Telehealth Expands Access but Fails to Build Patient Trust

Telehealth has made it easier than ever to explore medical cannabis.

71% of participants were aware of telehealth platforms offering evaluations
However, 48% were uncertain about the legitimacy or compliance of these platforms

People are open to using digital platforms, but many still question their validity and reliability. Common concerns included whether providers are licensed, whether approvals are legally recognized, and whether the process aligns with state regulations.
So while telehealth reduces friction, it does not automatically remove doubt.

Stigma Remains a Significant Barrier

Even in a state where cannabis is widely accepted, stigma continues to influence behavior.

39% of participants reported hesitation due to social or professional judgment
31% said they were uncomfortable discussing cannabis use with a healthcare provider

What’s changed is not the presence of stigma, but its form.

It is no longer about legality, but it is more about perception. Patients remain cautious about how their decisions may be perceived by others, including employers, peers, and even medical professionals.

This creates hesitation at a psychological level, even when access is readily available.

Lack of Process Clarity Remains a Major Factor

Another consistent pattern was confusion around how the medical cannabis process actually works.

58% were unclear about the qualifying condition
46% did not know what happens after approval
52% lacked clarity on legal protections and limits

Many participants described the process as fragmented. They would gather information from different sources, but still feel uncertain about the full journey.

Recreational Users Are Unaware of Medical Benefits

Among recreational cannabis users, awareness of medical program benefits was surprisingly low.

57% were unaware of the benefits associated with medical cannabis

For many users, recreational cannabis feels easier not because it is better, but because it is more familiar.

Medical cannabis, on the other hand, feels less understood. And when something isn’t fully understood, people tend to avoid it.

Behavioral Insights

Beyond the numbers, a few behavioral patterns consistently emerged:

Patients tend to delay decisions when information is unclear
Trust plays a central role in decision-making
Users prefer guided processes over self-navigation
First-time users rely heavily on legitimacy

These insights reinforce a key idea: access alone does not drive navigation, but confidence does.

Discussion

The findings suggest that the medical cannabis ecosystem in California has reached a stage where accessibility has advanced faster than patient education.

The challenge is no longer about whether patients can access medical cannabis. It is about whether they understand how to use it effectively and confidently. Patients are no longer asking if access is possible. They are asking whether the process is clear, legitimate, and right for them. This represents a shift from infrastructure-driven growth to experience-driven adoption.

Implications for the Industry

The results of this study indicate that future growth in medical cannabis will depend on addressing the gap between accessibility and understanding.
Key areas of focus include:

Improving patient education through clear and structured information
Enhancing transparency in telehealth processes
Building trust through compliance and communication
Reducing stigma through awareness and normalization

Organizations that address these areas are more likely to improve patient confidence and engagement.

Recommendations for Improving Patient Understanding

1. Simplifying Eligibility Communication

A large portion of participants remain unclear about the qualification criteria. Clear, condition-based guidance may help reduce this uncertainty.
2. Enhancing Transparency in Telehealth Processes
Concerns around legitimacy highlight the need for greater transparency. Clearly presenting provider credentials and legal validity may help build patient trust.

3. Introducing Guided, Step-by-Step Patient Journeys

Users show a strong preference for guided experiences over self-navigation. Structured, step-by-step explanations of processes may reduce confusion and improve confidence.

4. Addressing Stigma Through Education and Normalization

Stigma continues to influence decision-making despite legal acceptance. Educational, clinician-backed content may help normalize medical cannabis as a legitimate treatment option.

5. Increasing Awareness of Medical Benefits Among Recreational Users

Many recreational users are unaware of the advantages of a medical program. Clear comparisons around benefits and protections may support more informed decision-making.

6. Strengthening Trust Through Consistent and Reliable Information

Trust plays a central role in patient decisions. Providing consistent, accurate, and easy-to-understand information may reduce hesitation.

robert saint laurent author of my mmj doctor

Robert D. Saint Laurent, M.Ed.

Health & Medical Content Writer • Editorial Specialist

Robert D. Saint Laurent is an experienced health and medical content writer and editorial specialist with nearly three decades of experience creating clear, audience-focused content across digital and print platforms. He specializes in translating complex medical, health, and wellness information into accessible, research-driven messaging to support reader understanding.

View Profile

Conclusion

This study highlights a critical gap in the current medical cannabis landscape.

While access has improved significantly, understanding has not kept pace. The gap between accessibility and understanding is now one of the most important challenges in the industry.

Bridging this gap will require a shift in focus from simply enabling access to actively supporting patient clarity and confidence. Because in healthcare, access creates opportunity, but understanding drives action.

References

Valencia, C. I., Asaolu, I. O., Ehiri, J. E., & Rosales, C. (2017). Structural barriers in access to medical marijuana in the USA- a systematic review protocol. Systematic reviews, 6(1), 154.
King, D. D., et al. (2024). The role of stigma in cannabis use disclosure in U.S. healthcare settings. National Library of Medicine.
Ageze, D., et al. (2025). Medicinal and recreational cannabis use patterns in a post-legalization environment. Springer Nature.
Levy S, Meghani S, Worster B, Kilanowski C, Smith D, Case AA, Ashare RL. Cannabis stigma and symptom management considerations in cancer survivors: a mixed-methods exploration of patient perspectives. Support Care Cancer. 2026 Mar 13;34(4):313. doi: 10.1007/s00520-026-10523-2. PMID: 41820694; PMCID: PMC12982309.



Ready to Get Started?

See if you qualify for medical cannabis therapy.

Get Your Card

Continue your medical cannabis education with these expert-reviewed articles.